Literature DB >> 4049040

Treatment of myasthenic crisis in late life.

M S Sellman, R F Mayer.   

Abstract

In 32 patients with the onset of myasthenia gravis after age 50, myasthenic crisis occurred in 53% and persisted for a mean of 33 days (range six to 84 days). Three of the patients had a second crisis. Precipitating factors were found in 60% of the episodes. Treatment of 20 episodes of crisis resulted in excellent recovery. No patient died in crisis. All regained enough function to return home. Those patients (50%) who had no medical complications recovered most rapidly. The most common medical complications were aspiration and bacterial pneumonia, cardiac arrhythmias, and congestive heart failure. Large doses of prednisone in combination with serial plasma exchanges was the most effective therapy. This group of patients had the fewest medical complications (29%) and the fastest recovery.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4049040     DOI: 10.1097/00007611-198510000-00017

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  6 in total

1.  Beneficial effects of plasmapheresis before thymectomy on the outcome in myasthenia gravis.

Authors:  Takeshi Nagayasu; Takatomo Yamayoshi; Keitaro Matsumoto; Noboru Ide; Satoshi Hashizume; Masahito Nomura; Masashi Muraoka; Tsutomu Tagawa; Shinji Akamine; Tadayuki Oka
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2005-01

Review 2.  Myasthenia gravis.

Authors:  Vern C Juel; Janice M Massey
Journal:  Orphanet J Rare Dis       Date:  2007-11-06       Impact factor: 4.123

3.  Clinical profile and outcome of myasthenic crisis in a tertiary care hospital: A prospective study.

Authors:  Sudhir Sharma; Vivek Lal; Sudesh Prabhakar; Ritesh Agarwal
Journal:  Ann Indian Acad Neurol       Date:  2013-04       Impact factor: 1.383

4.  Predictors of extubation outcomes following myasthenic crisis.

Authors:  Zhenguo Liu; Shiyuan Yao; Qian Zhou; Zhensheng Deng; Jianyong Zou; Huiyu Feng; Hua Zhu; Chao Cheng
Journal:  J Int Med Res       Date:  2016-11-18       Impact factor: 1.671

5.  Trends in Outcomes and Hospitalization Charges among Mechanically Ventilated Patients with Myasthenia Gravis in the United States.

Authors:  Nizar Souayah; Abu Nasar; M Fareed K Suri; Jawad F Kirmani; Mustapha A Ezzeddine; Adnan I Qureshi
Journal:  Int J Biomed Sci       Date:  2009-09

Review 6.  Acetylcholinesterase Inhibitors in Myasthenic Crisis: A Systematic Review of Observational Studies.

Authors:  Mario B Prado; Karen Joy Adiao
Journal:  Neurocrit Care       Date:  2021-07-22       Impact factor: 3.210

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.